FDA rebuffed the drug compounding industry's concerns that the agency was premature in reaching out to governors, health departments, boards of pharmacy and hospital purchasers to encourage them to use outsourcing facilities registered with the agency.
subscription required to read at InsideHealthPolicy.com
No comments:
Post a Comment